What are the challenges in prescribing pharmacotherapy for female sexual dysfunctions?

Rossella E. Nappi; Barbara Gardella

doi:10.1080/14656566.2019.1582644

What are the challenges in prescribing pharmacotherapy for female sexual dysfunctions?

IRCCS Fondazione Policlinico San Matteo

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Journal	Expert Opinion on Pharmacotherapy
DOIs	https://doi.org/10.1080/14656566.2019.1582644
Publication status	Published - Jan 1 2019

Keywords

bremelanotide
DHEA
female sexual dysfunctions (FSDs)
flibanserin
hypoactive sexual desire disorder (HSDD)
ospemifene
Sexual education
vulvovaginal atrophy/genitourinary syndrome of menopause (VVA/GSM)

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

Access to Document

10.1080/14656566.2019.1582644

Cite this

@article{5d3ebb03548045ac9d03e5f19a37623c,

title = "What are the challenges in prescribing pharmacotherapy for female sexual dysfunctions?",

keywords = "bremelanotide, DHEA, female sexual dysfunctions (FSDs), flibanserin, hypoactive sexual desire disorder (HSDD), ospemifene, Sexual education, vulvovaginal atrophy/genitourinary syndrome of menopause (VVA/GSM)",

author = "Nappi, {Rossella E.} and Barbara Gardella",

year = "2019",

month = jan,

day = "1",

doi = "10.1080/14656566.2019.1582644",

language = "English",

journal = "Expert Opinion on Pharmacotherapy",